[1]徐成润　综述,伍伟平　审校.PD-1/PD-L1负性协同刺激通路在乙型病毒性肝炎慢性化中的地位及进展[J].医学研究与战创伤救治(原医学研究生学报),2015,17(05):514-516，523.[doi:10.3969/j.issn.1672-271X.2015.05.021]

点击复制

PD-1/PD-L1负性协同刺激通路在乙型病毒性肝炎慢性化中的地位及进展()

分享到62.8K

参考文献/References:

[1]Zhang JY，Zhang Z，Jin B，et al.Cutting edge：programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection[J].J Immunol，2008，181(6):3741-3744.
[2]Muenst S，Soysal SD，Tzankov A，et al.The PD-1/PD-L1 pathway：biological background and clinical relevance of an emerging treatment target in immunotherapy[J].Expert Opin Ther Targets，2015，19(2):201-211.
[3]Dai S，Jia R，Zhang X，et al.The PD-1/PD-Ls pathway and autoimmune diseases[J].Cell Immunol，2014，290(1):72-79.
[4]Boussiotis VA，Chatterjee P，Li L.Biochemical signaling of PD-1 on T cells and its functional implications[J].Cancer J，2014，20(4):265-271.
[5]El Annan J，Goyal S，Zhang Q，et al.Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation [J].Invest Ophthalmol Vis Sci，2010，51(7):3418-3423.
[6]Liu Y，Zhao M，Xu X，et al.Adoptive transfer of Treg cells counters adverse effects of Toxoplasma gondii infection on pregnancy[J].J Infect Dis，2014， 210(9):1435-1443.
[7]Ghiotto M，Gauthier L，Serriari N，et al.PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1[J].Int Immunol，2010，22(8):651- 660.
[8]Tang X，Li Q，Zhu Y，et al.The advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapy[J].Am J Transl Res，2015，7(3):460-473.
[9]Butte MJ，Pena-Cruz V，Kim MJ，et al.Interaction of human PD-L1 and B7-1[J].Mol Immunol，2008，45(13):3567-3572.
[10]Won TJ，Jung YJ，Kwon SJ，et al.Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes[J].Arch Pharm Res，2010 ，33(11):1825-1833.
[11]Mfarrej B，Keir M，Dada S，et al.Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditis[J].Clin Immunol，2011，140 (1):47-53.
[12]Park HJ，Park JS，Jeong YH，et al.PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell Immune response via the interaction with PD-L1 expressed on CD8+ T cells[J].J Immunol，2015，194(12):5801-5811.
[13]Franceschini D，Paroli M，Francavilla V，et al.PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV[J].J Clin Invest，2009，119(3):551-564.
[14]Klenerman P，Hill A.T cells and viral persistence：lessons from diverse infections[J].Nat Immunol，2005，6(9):873-879.
[15]Onlamoon N，Rogers K，Mayne AE，et al.Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection[J].Immunology，2008，124(2):277-293.
[16]Planes R，BenMohamed L，Leghmari K，et al.HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms[J].J Virol，2014，88(12):6672-6689.
[17]Penaloza-MacMaster P，Kamphorst AO，Wieland A，et al.Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection[J].J Exp Med，2014，211(9):1905-1918.
[18]Su SS，He H，Kong LB，et al.Regulatory phenotype，PD-1 and TLR3 expression in T cells and monocytes from HCV patients undergoing antiviral therapy：a randomized clinical trial[J].PLoS One，2014，9(4):e93620.
[19]Shi F，Shi M，Zeng Z，et al.PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients[J].Int J Cancer，2011，128(4):887-896.
[20]Palmer BE，Neff CP，Lecureux J，et al.In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice[J].J Immunol，2013，190(1):211-219.
[21]Dai B，Xiao L，Bryson PD，et al.PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines[J].Mol Ther，2012，20(9):1800-1809.
[22]Iwai Y，Terawaki S，Ikegawa M，et al.PD-1 inhibits antiviral immunity at the effector phase in the liver[J].J Exp Med，2003，198(1):39-50.
[23]Dong H，Zhu G，Tamada K，et al.B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes[J].Immunity，2004，20(3):327-336.
[24]Cai G，Nie X，Li L，et al.B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function[J].J Gastroenterol，2013，48(12):1362-1372.
[25]Xu P，Chen YJ，Chen H，et al.The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics[J].Gut Liver，2014，8(2):186-195.
[26]Boni C，Fisicaro P，Valdatta C，et al.Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection[J].J Virol，2007， 81(8):4215-4225.
[27]Hou FQ，Wu XJ，Wang Y，et al.Rapid downregulation of programmed death-1 and interferon-gamma-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B[J].J Viral Hepat，2013，20(Suppl 1):18-26.

相似文献/References: